edibles and glp 1 Are Safer Than Smoking? New Study Sheds Light on Cannabis Heart Problems GLP-1 Drugs and Consumer Preferences:

Semaglutide: Targets the GLP-1 pathway only Focuses on appetite regulation and fullness Tirzepatide: Targets both GLP-1 and GIP pathways May create a broader metabolic response Although this difference sounds technical, it can influence how patients respond to treatment

These effects are generally mild to moderate in severity and tend to diminish over time as patients develop tolerance ^1

Whilst transdermal patch formulations represent an area of ongoing pharmaceutical research, no GLP-1 patches are currently licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) or approved by the National Institute for Health and Care Excellence (NICE) for use in the United Kingdom

Ultimately, the decision to continue or discontinue GLP-1 treatment after reaching your weight loss goal should be based on a comprehensive assessment of your individual health needs, potential benefits, and any risks associated with long-term use of the medication

As we look ahead, its clear that understanding the impact of these therapies will be essential for shaping the future of healthcare, insurance, and public health